Discordance, accuracy and reproducibility study of pathologists’ diagnosis of melanoma and melanocytic tumors

S Sarah Haggenmüller C Christoph Wies J Julia Abels J Jana T. Winterstein L Lukas Heinlein C Carina Nogueira Garcia J Jochen S. Utikal S Sebastian A. Wohlfeil F Friedegund Meier S Sarah Hobelsberger F Frank F. Gellrich M Mildred Sergon A Axel Hauschild (Department of Dermatology, University Hospital, Kiel, Germany) L Lars E. French L Lucie Heinzerling J Justin G. Schlager K Kamran Ghoreschi M Max Schlaak F Franz J. Hilke G Gabriela Poch S Sören Korsing C Cosimo Sarfert C Carola Berking M Markus V. Heppt M Michael Erdmann (Department of Dermatology, Uniklinikum Erlangen, Friedrich Alexander University) S Sebastian Haferkamp K Konstantin Drexler D Dirk Schadendorf W Wiebke Sondermann M Matthias Goebeler B Bastian Schilling J Jakob Nikolas Kather S Stefan Fröhling M Mar Llamas-Velasco L Luis C. Requena G Gerardo Ferrara M Maite Fernandez-Figueras S Sylvie Fraitag (Laboratoire d’Anatomie Pathologique, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris) C Cornelia S. L. Müller H Hans Starz H Heinz Kutzner R Raymond Barnhill R Richard Carr K Kenneth S. Resnik S Stephan Alexander Braun T Tim Holland-Letz T Titus J. Brinker

Abstract

Abstract Accurate melanoma diagnosis is crucial for patient outcomes and reliability of AI diagnostic tools. We assess interrater variability among eight expert pathologists reviewing histopathological images and clinical metadata of 792 melanoma-suspicious lesions prospectively collected at eight German hospitals. Moreover, we provide access to the largest panel-validated dataset featuring dermoscopic and histopathological images with metadata. Complete agreement is achieved in 53.5% of cases (424/792), and a majority vote ( ≥ five pathologists) in 90.9% (720/792). Considerable discordance is observed for non-invasive melanomas (complete agreement in only 10/73 cases). The expert panel disagrees with the local pathologists’ and dermatologists’ diagnoses in 14.9% and 33.5% of cases, respectively. This variability highlights the diagnostic challenges of early-stage melanomas and the need to reconsider how ground truth is established in routine care and AI research. Including at least two pathologists or virtual panels may contribute to more consistent diagnostic results.

Article Details

Volume / Issue Vol. 16, Issue 1
Published January 17, 2025
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (47)

S

Sarah Haggenmüller

C

Christoph Wies

J

Julia Abels

J

Jana T. Winterstein

L

Lukas Heinlein

C

Carina Nogueira Garcia

J

Jochen S. Utikal

S

Sebastian A. Wohlfeil

F

Friedegund Meier

S

Sarah Hobelsberger

F

Frank F. Gellrich

M

Mildred Sergon

A

Axel Hauschild

Department of Dermatology, University Hospital, Kiel, Germany

L

Lars E. French

L

Lucie Heinzerling

J

Justin G. Schlager

K

Kamran Ghoreschi

M

Max Schlaak

F

Franz J. Hilke

G

Gabriela Poch

S

Sören Korsing

C

Cosimo Sarfert

C

Carola Berking

M

Markus V. Heppt

M

Michael Erdmann

Department of Dermatology, Uniklinikum Erlangen, Friedrich Alexander University

S

Sebastian Haferkamp

K

Konstantin Drexler

D

Dirk Schadendorf

W

Wiebke Sondermann

M

Matthias Goebeler

B

Bastian Schilling

J

Jakob Nikolas Kather

S

Stefan Fröhling

M

Mar Llamas-Velasco

L

Luis C. Requena

G

Gerardo Ferrara

M

Maite Fernandez-Figueras

S

Sylvie Fraitag

Laboratoire d’Anatomie Pathologique, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris

C

Cornelia S. L. Müller

H

Hans Starz

H

Heinz Kutzner

R

Raymond Barnhill

R

Richard Carr

K

Kenneth S. Resnik

S

Stephan Alexander Braun

T

Tim Holland-Letz

T

Titus J. Brinker